title: [Somatomedin C level and stimulation of growth hormone and adrenal cortex function by administration of releasing hormones and physical exertion in patients with obesity].
abstract: In a clinical study on potential determinants underlying the impairment of growth hormone stimulation in obese human subjects, we examined in 20 otherwise healthy adult obese subjects (14 females, six males, age 18 to 40 years, body mass index greater than 29 kg/m2) the responses of growth hormone (hGH), adrenocorticotropic hormone (ACTH) and cortisol to releasing hormone stimulation (growth hormone-releasing hormone and corticotropin-releasing hormone) and the responses of hGH, ACTH, cortisol and free fatty acids (FFA) to physical exercise. Subjects with somatomedin-C levels less than or equal to 0.7 U/ml (group 1) were more obese than subjects with somatomedin-C levels greater than 0.7 U/ml (group 2) (p less than 0.01). In group 1, hGH increased by 4.3 +/- 1.2 ng/ml in response to releasing hormone administration and by 0.9 +/- 0.3 ng/ml in response to physical exercise (normal responses, increase by greater than 7 ng/ml), in group 2, hGH increased by 6.7 +/- 1.4, and 2.4 +/- 0.8 ng/ml, respectively (p less than 0.05 vs. group 1). Moreover, FFA stimulation by physical exercise was blunted in group 1 (p less than 0.05 vs. group 2). In contrast, ACTH stimulation was found increased in group 1 in comparison to group 2, particularly in response to physical exercise (p less than 0.01), and resulted in enhanced cortisol stimulation (p less than 0.05). Thus, impaired hGH stimulation in obese human subjects is not explained by an altered relationship between hGH and somatomedin-C levels.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Abteilung für Endokrinologie, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt am Main.
authors.forename: E
authors.initials: E
authors.lastname: Jungmann
authors.forename: M
authors.initials: M
authors.lastname: Stahr
authors.forename: G
authors.initials: G
authors.lastname: Schwietzer
authors.forename: T
authors.initials: T
authors.lastname: Nickelsen
authors.forename: K
authors.initials: K
authors.lastname: Schmidt
authors.forename: P M
authors.initials: PM
authors.lastname: Schumm-Draeger
authors.forename: P H
authors.initials: PH
authors.lastname: Althoff
authors.forename: K
authors.initials: K
authors.lastname: Schöffling
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000097:blood*; D000328:Adult; D003346:Corticotropin-Releasing Hormone; D005080:Exercise Test; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D013006:Growth Hormone / Q000097:blood; D013007:Growth Hormone-Releasing Hormone; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000097:blood*
chemical_list: D000305:Adrenal Cortex Hormones; D005230:Fatty Acids, Nonesterified; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D003346:Corticotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone; D006854:Hydrocortisone
vernacular_title: Somatomedin-C-Spiegel und Stimulation von Wachstumshormon und Nebennierenrindenfunktion durch Gabe von Releasing-Hormonen und körperliche Belastung bei Patienten mit Adipositas.